search
Back to results

An Online Intervention Addressing Mental Health and Substance Use in University Students

Primary Purpose

Anxiety, Depression, Alcohol Use

Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Minder
Sponsored by
University of British Columbia
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Anxiety focused on measuring Student Mental Health, Anxiety, Depression, Alcohol Use, Substance Use, Cannabis Use, Opioid Use, Stimulant Use, Online Intervention, E-mental Health

Eligibility Criteria

17 Years - undefined (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Must be currently enrolled at participating university Must be 17 years or older Must have access to and be able to use a smart phone with Wi-Fi and/or mobile data Must be English speaking Exclusion Criteria: 1) Any participants that self-identify as currently having a suicidal plan at the time of study enrollment

Sites / Locations

  • University of British Columbia

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Intervention arm

Control arm

Arm Description

Participants randomized into the intervention arm will be given immediate access to a fully functional version of the Minder app that includes baseline, interim and follow-up surveys and access to all app components and e-coaching.

Participants randomized into the control arm will be given access to a restricted version of the app that only includes access to a generic study introduction video and baseline and follow up survey assessments delivered via the app.

Outcomes

Primary Outcome Measures

Change in General anxiety symptomology from Baseline to Follow-up at 30 days
Assessed by the General Anxiety Disorder 7-Item (GAD-7) scale. Changes in anxiety symptomology from baseline to follow-up at 30 days will be based on total scores on the GAD-7 in both the intervention and control groups. Total scores range from 0 to 21 with higher scores indicating a worse outcome (i.e, a greater frequency of anxiety symptoms).
Change in Depressive symptomology from Baseline to Follow-up at 30 days
Assessed by the Patient Health Questionnaire 9-item (PHQ-9) scale. Changes in depressive symptomology from baseline to follow-up at 30 days will be based on total scores on the PHQ-9 in both the intervention and control groups. Total scores range from 0 to 29 with higher scores indicating a worse outcome (i.e., a greater frequency of depression symptoms).
Change in Alcohol consumption risk from Baseline to Follow-up at 30 days
Assessed by the alcohol consumption questions of the Alcohol Use Disorders Identification Test, Adapted for Use in the United States (USAUDIT-C). Changes in alcohol consumption risk from baseline to follow-up at 30 days will be based on total scores on the USAUDIT-C in both the intervention and control groups. Total scores range from 0 to 18 with higher scores indicating a worse outcome (i.e., a higher level of risky drinking).

Secondary Outcome Measures

Frequency of cannabis consumption
Changes in frequency of cannabis consumption from baseline to follow-up at 30 days will be based on self-reported frequency of cannabis consumption in both the intervention and control groups.
Frequency of binge drinking
Changes in frequency of binge drinking from baseline to follow-up at 30 days will be based on responses to item 3 of the USAUDIT-C in both the intervention and control groups.
Frequency of alcohol use
Changes in frequency of alcohol use from baseline to follow-up at 30 days will be based on responses to items 1 and 2 of the USAUDIT-C in both the intervention and control groups.
Frequency of opioid use
Changes in frequency of opioid use from baseline to follow-up at 30 days will be based on self-reported frequency of both medical and non-medical opioid use in both the intervention and control groups.
Frequency of non-medical stimulant use
Changes in frequency of non-medical stimulant use from baseline to follow-up at 30 days will be based on self-reported frequency of non-medical stimulant use in both the intervention and control groups.
Self-efficacy related to the management of substance use.
Changes in substance use self-efficacy from baseline to follow-up at 30 days will be based on self-reported measures in both the intervention and control groups. This is based on answers to the following 4 self-report survey questions assess different aspects of self-efficacy related to the management of substance use. Each question is scored separately using a response ranging from 1 (Not all confident) to 5 (Totally confident) with higher scores indicating a better outcome (i.e., greater self-efficacy). How confident are you that you could effectively manage any substance use problems you experience (e.g., cannabis, alcohol or other drugs)? How confident are you that you could manage your substance use without reaching out to the health system or other support services? How confident are you that you would know how to access substance use services if you felt you needed them? How likely are you to reach out to substance use services if you felt you needed them?
Readiness to change
Changes in level of readiness to change from baseline to follow-up at 30 days for the use of individual substances (alcohol, cannabis, opioids, and stimulants) will be based on responses to self-reported readiness to change ladder assessments in both the intervention and control groups. The self-reported readiness to change ladder assessments are single item self-report survey questions for each substance that ask participants to rate their readiness to change using a single Likert-type response scale that ranges from 0 (No thought of changing) to 10 (Taking action to change) with higher scores indicating a better outcome (i.e., higher readiness to change).
Mental Well-being
Changes in mental well-being from baseline to follow-up at 30 days will be based on total scores from the Short Warwick-Edinburgh Mental Wellbeing Scale in both the intervention and control groups. Total scores range from 7 to 35 with higher scores indicating better outcome (i.e., higher positive mental wellbeing).
Self-efficacy related to the management of mental health.
Changes in mental health self-efficacy from baseline to 30-day follow-up are based on 5 self-reported survey questions in the intervention and control groups. Each question is scored separately using a Likert-type response ranging from 1 (Not at all confident/likely) to 5 (Totally confident/likely) with higher scores indicating a better outcome (i.e., greater self-efficacy). How confident are you that you could effectively manage any mental health problems you experience (e.g., stress, anxiety or depression)? How confident are you that you could manage your mental health without reaching out to the health system or other support services? How confident are you that you would know how to access mental health services if you felt you needed them? How likely are you to reach out to mental health services if you felt you needed them? How confident are you that you can manage your mental health problems without using alcohol or other drugs as a coping strategy?
Self-reported use of mental health services and supports
Changes in the use of mental health services and supports from baseline to 30-day follow-up will be based on responses to 2 self-reported survey questions in both the intervention and control groups. Change will be assessed by comparing responses to each question (yes or no) at baseline to 30-day follow-up. The questions ask if they have been diagnosed or treated by a professional for a list of conditions and whether they have used any mental health treatments (medication, psychotherapy, mindfulness, and online tools) in the past 30 days and currently. Two additional self-reported survey questions on accessing types of support services and having joined any university clubs or participated in any club-related events are only asked at 30-day follow-up.

Full Information

First Posted
September 2, 2022
Last Updated
September 14, 2023
Sponsor
University of British Columbia
search

1. Study Identification

Unique Protocol Identification Number
NCT05606601
Brief Title
An Online Intervention Addressing Mental Health and Substance Use in University Students
Official Title
An Integrated Online Intervention Addressing Mental Health and Substance Use in University Students: A Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Completed
Study Start Date
September 28, 2022 (Actual)
Primary Completion Date
July 21, 2023 (Actual)
Study Completion Date
July 21, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of British Columbia

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to assess the effectiveness of mobile app containing a range of evidence based tools to improve the mental health and substance use outcomes of university students.
Detailed Description
There is a need for scalable interventions to support the mental health and substance use challenges experienced by university students. One means of addressing this need is through the use of e-mental health tools that facilitate self-management and connect students to in-person supports as needed. This is a randomized controlled trial of a mobile app designed to help university students manage their mental health and substance use via a set of evidence-based tools that have been integrated into a single mobile app. The recruitment of approximately 1500 students will occur through social media, promotion by faculty members and administrators, and other in-person recruitment methods. Assessments will be conducted using self-report web surveys at baseline, 14 days (interim assessment) and 30 days (follow-up assessment). The goal of the trial is to assess the effectiveness of the app in improving a range of mental health and substance use outcomes of university students from baseline to follow-up.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Anxiety, Depression, Alcohol Use, Substance Use
Keywords
Student Mental Health, Anxiety, Depression, Alcohol Use, Substance Use, Cannabis Use, Opioid Use, Stimulant Use, Online Intervention, E-mental Health

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Investigator
Masking Description
Single blinded in that only the investigators (including the statistician) will be blinded to the treatment group assignment when examining the primary hypotheses.
Allocation
Randomized
Enrollment
1489 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intervention arm
Arm Type
Experimental
Arm Description
Participants randomized into the intervention arm will be given immediate access to a fully functional version of the Minder app that includes baseline, interim and follow-up surveys and access to all app components and e-coaching.
Arm Title
Control arm
Arm Type
No Intervention
Arm Description
Participants randomized into the control arm will be given access to a restricted version of the app that only includes access to a generic study introduction video and baseline and follow up survey assessments delivered via the app.
Intervention Type
Behavioral
Intervention Name(s)
Minder
Intervention Description
There are four main components of the Minder app: The Chatbot, Services, Community, and Peer Coaching components. The Services component asks participants to complete a series of questions on various mental health, substance use, and general life issues. It then recommends community and on-campus resources based on their current needs. The Community component of the app matches individuals with groups (e.g., student clubs) and events at the university or in the broader community that they may be interested in. The Chatbot component of the app contains pre-formatted conversational scripts that users engage with via a "chatbot" and videos designed to teach evidence-based skills (e.g., cognitive strategies to manage anxiety) that can be applied to everyday life. To support use of the app, all users in the intervention group will be offered access to trained peer coaches to help users navigate the different app components and provide non-clinical peer support.
Primary Outcome Measure Information:
Title
Change in General anxiety symptomology from Baseline to Follow-up at 30 days
Description
Assessed by the General Anxiety Disorder 7-Item (GAD-7) scale. Changes in anxiety symptomology from baseline to follow-up at 30 days will be based on total scores on the GAD-7 in both the intervention and control groups. Total scores range from 0 to 21 with higher scores indicating a worse outcome (i.e, a greater frequency of anxiety symptoms).
Time Frame
The GAD-7 will be administered to both the intervention and control groups at baseline and 30 days.
Title
Change in Depressive symptomology from Baseline to Follow-up at 30 days
Description
Assessed by the Patient Health Questionnaire 9-item (PHQ-9) scale. Changes in depressive symptomology from baseline to follow-up at 30 days will be based on total scores on the PHQ-9 in both the intervention and control groups. Total scores range from 0 to 29 with higher scores indicating a worse outcome (i.e., a greater frequency of depression symptoms).
Time Frame
The PHQ-9 will be administered to both the intervention and control group at baseline and 30 days.
Title
Change in Alcohol consumption risk from Baseline to Follow-up at 30 days
Description
Assessed by the alcohol consumption questions of the Alcohol Use Disorders Identification Test, Adapted for Use in the United States (USAUDIT-C). Changes in alcohol consumption risk from baseline to follow-up at 30 days will be based on total scores on the USAUDIT-C in both the intervention and control groups. Total scores range from 0 to 18 with higher scores indicating a worse outcome (i.e., a higher level of risky drinking).
Time Frame
The USAUDIT-C will be administered to the intervention and control groups at baseline and 30 days.
Secondary Outcome Measure Information:
Title
Frequency of cannabis consumption
Description
Changes in frequency of cannabis consumption from baseline to follow-up at 30 days will be based on self-reported frequency of cannabis consumption in both the intervention and control groups.
Time Frame
Frequency of cannabis consumption will be assessed in the intervention and control groups at baseline and at 30 days.
Title
Frequency of binge drinking
Description
Changes in frequency of binge drinking from baseline to follow-up at 30 days will be based on responses to item 3 of the USAUDIT-C in both the intervention and control groups.
Time Frame
Frequency of binge drinking will be assessed in the intervention and control groups at baseline and at 30 days.
Title
Frequency of alcohol use
Description
Changes in frequency of alcohol use from baseline to follow-up at 30 days will be based on responses to items 1 and 2 of the USAUDIT-C in both the intervention and control groups.
Time Frame
Frequency of alcohol use will be assessed in the intervention and control groups at baseline and at 30 days.
Title
Frequency of opioid use
Description
Changes in frequency of opioid use from baseline to follow-up at 30 days will be based on self-reported frequency of both medical and non-medical opioid use in both the intervention and control groups.
Time Frame
Frequency of opioid use will be assessed in the intervention and control groups at baseline and at 30 days.
Title
Frequency of non-medical stimulant use
Description
Changes in frequency of non-medical stimulant use from baseline to follow-up at 30 days will be based on self-reported frequency of non-medical stimulant use in both the intervention and control groups.
Time Frame
Frequency of non-medical stimulant use will be assessed in the intervention and control groups at baseline and at 30 days.
Title
Self-efficacy related to the management of substance use.
Description
Changes in substance use self-efficacy from baseline to follow-up at 30 days will be based on self-reported measures in both the intervention and control groups. This is based on answers to the following 4 self-report survey questions assess different aspects of self-efficacy related to the management of substance use. Each question is scored separately using a response ranging from 1 (Not all confident) to 5 (Totally confident) with higher scores indicating a better outcome (i.e., greater self-efficacy). How confident are you that you could effectively manage any substance use problems you experience (e.g., cannabis, alcohol or other drugs)? How confident are you that you could manage your substance use without reaching out to the health system or other support services? How confident are you that you would know how to access substance use services if you felt you needed them? How likely are you to reach out to substance use services if you felt you needed them?
Time Frame
Substance use self-efficacy will be assessed in the intervention and control groups at baseline and at 30 days.
Title
Readiness to change
Description
Changes in level of readiness to change from baseline to follow-up at 30 days for the use of individual substances (alcohol, cannabis, opioids, and stimulants) will be based on responses to self-reported readiness to change ladder assessments in both the intervention and control groups. The self-reported readiness to change ladder assessments are single item self-report survey questions for each substance that ask participants to rate their readiness to change using a single Likert-type response scale that ranges from 0 (No thought of changing) to 10 (Taking action to change) with higher scores indicating a better outcome (i.e., higher readiness to change).
Time Frame
Readiness to change will be assessed in the intervention and control groups at baseline and at 30 days.
Title
Mental Well-being
Description
Changes in mental well-being from baseline to follow-up at 30 days will be based on total scores from the Short Warwick-Edinburgh Mental Wellbeing Scale in both the intervention and control groups. Total scores range from 7 to 35 with higher scores indicating better outcome (i.e., higher positive mental wellbeing).
Time Frame
The Short Warwick-Edinburgh Mental Wellbeing Scale will be administered in the intervention and control groups at baseline and at 30 days.
Title
Self-efficacy related to the management of mental health.
Description
Changes in mental health self-efficacy from baseline to 30-day follow-up are based on 5 self-reported survey questions in the intervention and control groups. Each question is scored separately using a Likert-type response ranging from 1 (Not at all confident/likely) to 5 (Totally confident/likely) with higher scores indicating a better outcome (i.e., greater self-efficacy). How confident are you that you could effectively manage any mental health problems you experience (e.g., stress, anxiety or depression)? How confident are you that you could manage your mental health without reaching out to the health system or other support services? How confident are you that you would know how to access mental health services if you felt you needed them? How likely are you to reach out to mental health services if you felt you needed them? How confident are you that you can manage your mental health problems without using alcohol or other drugs as a coping strategy?
Time Frame
Mental health self-efficacy will be assessed in the intervention and control groups at baseline and at 30 days.
Title
Self-reported use of mental health services and supports
Description
Changes in the use of mental health services and supports from baseline to 30-day follow-up will be based on responses to 2 self-reported survey questions in both the intervention and control groups. Change will be assessed by comparing responses to each question (yes or no) at baseline to 30-day follow-up. The questions ask if they have been diagnosed or treated by a professional for a list of conditions and whether they have used any mental health treatments (medication, psychotherapy, mindfulness, and online tools) in the past 30 days and currently. Two additional self-reported survey questions on accessing types of support services and having joined any university clubs or participated in any club-related events are only asked at 30-day follow-up.
Time Frame
Use of mental health services and supports will be assessed in the intervention and control groups at baseline and at 30 days.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Must be currently enrolled at participating university Must be 17 years or older Must have access to and be able to use a smart phone with Wi-Fi and/or mobile data Must be English speaking Exclusion Criteria: 1) Any participants that self-identify as currently having a suicidal plan at the time of study enrollment
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Daniel V Vigo, MD, Lic. Psych, DrPH
Organizational Affiliation
University of British Columbia
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of British Columbia
City
Vancouver
State/Province
British Columbia
ZIP/Postal Code
V6T 2A1
Country
Canada

12. IPD Sharing Statement

Learn more about this trial

An Online Intervention Addressing Mental Health and Substance Use in University Students

We'll reach out to this number within 24 hrs